HYDROmorphone Risk Reduction

facebook.com — “Coast Dermatology Medical Associates wrote: Dietary Fat Reduction May Not Be... Join Facebook to connect with Coast Dermatology Medical Associates and others you may know.” View full resource at facebook.com

Most Recently Shared on March 26, 2012 at 3:28 pm By:

Mark Horowitz Doctor, Dermatologist, and Physician

Dietary Fat Reduction May Not Be Associated With Decreased Skin Cancer Risk. Medscape (3/24, Johnson) reports,... http://t.co/YVS4eRR1

PhysOrg Health News Health News

Heart healthy lessons plus better food offerings lower heart disease risk factors in sixth-graders

medicalxpress.com — “Sixth-graders taking part in a 10-week program that included interactive lessons to get heart smart coupled with healthier food and beverage options in the cafeteria and vending machines had marked reductions across all cardiovascular risk factors, according to research presented today at the American ...” View full resource at medicalxpress.com

Most Recently Shared on March 26, 2012 at 2:57 pm By:

Heart healthy lessons plus better food offerings lower heart disease risk factors in sixth-graders http://t.co/JDcIUvQW

Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency | LinkedIn

events.linkedin.com — “PROGRAM OVERVIEW Statins dramatically reduce cardiovascular risk by lowering LDL-C levels, however, their use in some patients requires additional considerations, such as those with chronic kidney disease. In addition, there are significant safety and efficacy differences within the class that must be understood to ensure patients receive the optimal therapy and cardioprotective benefits of the class of drugs. Newer statins can achieve more pronounced LDL-C reductions at lower dosages, reducing ” View full resource at events.linkedin.com

Most Recently Shared on March 25, 2012 at 3:44 pm By:

James Underberg Doctor, Internist, and Physician

LinkedIn Events: Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency http://t.co/HLehljFL

Medical Advisor Journals - Home of Kyle J. Norton for The Better of Living & Living Health: Effect of weight reduction on cardiovascular risk factors

medicaladvisorjournals.blogspot.ca — “Please note that all articles written by Kyle. J. Norton are for information and education only, please consult with your doctor or related field specialist before applying.” View full resource at medicaladvisorjournals.blogspot.ca

Most Recently Shared on March 25, 2012 at 1:47 pm By:

Kyle J.Norton

Effect of weight reduction on cardiovascular risk factors http://t.co/QUe4la3h

WSJ Health Blog Health News

Studies Find New Evidence Aspirin May Prevent Cancer - WSJ.com

online.wsj.com — “A daily dose of aspirin may have more benefits than reducing heart-disease risk. It may also help prevent cancer, according to studies in The Lancet.” View full resource at online.wsj.com

Most Recently Shared on March 21, 2012 at 4:29 pm By:

Aspirin may do more than cut heart-disease risk—it may also help prevent cancer, as Sten Stovall explains: http://t.co/22bIpejL

Gannett Healthcare Health News

Protect Yourself! Men's Melanoma Risk | WEB112 > Content

ce.nurse.com — “The goal of this program is to provide an overview of melanoma as it relates to incidence, risk factors, and steps for risk reduction. Upon completion of this webinar, participants will be able to: Describe different types of skin cancer Discuss incidence of melanoma List risk factors for melanoma Identify steps for risk reduction Understand treatment options” View full resource at ce.nurse.com

Most Recently Shared on March 21, 2012 at 4:01 pm By:

Spring (SUN) is here! Time to refresh your knowledge of melanoma with this @nursedotcom CE course: http://t.co/Vt1a7g28

Healthcare Channel Health Site

Limitations of The Lancet papers espousing the cancer risk reduction of daily aspirin | CurrentMedicine.tv

currentmedicine.tv — “March 21, 2012 By Dr. Kausik Ray from St. George's University in London Here are my thoughts on The recent Lancet papers that uses meta-analysis to study” View full resource at currentmedicine.tv

Most Recently Shared on March 21, 2012 at 3:35 pm By:

New article from contributor: Limitations of The Lancet papers espousing the cancer risk reduction of daily aspirin http://t.co/EuquKqXB

Aspirin a day may keep cancer away | StarTribune.com

startribune.com — “Taking aspirin every day may significantly reduce the risk of many cancers and prevent tumors from spreading, according to two new studies published Tuesday” View full resource at startribune.com

Most Recently Shared on March 21, 2012 at 1:16 am By:

Susan S Health Advocate

Aspirin a day may keep cancer away: Two new studies find significant reductions. http://t.co/Em7HH0Co

MedicalFeed Health News Feed

Aspirin Benefits May Include Cancer Prevention (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- Regular aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality, according to one of the largest-ever analyses of published data.” View full resource at qualitypointtech.net

Most Recently Shared on March 20, 2012 at 10:45 pm By:

Aspirin Benefits May Include Cancer Prevention (CME/CE): (MedPage Today) -- Regular aspirin use leads to significa... http://t.co/q10WG4RD

Lungs and Breathing OW Health

Statins May Lower Pneumonia Risk - ABC News

abcnews.go.com — “Statins, the same drugs that help millions of Americans control their cholesterol may also help prevent pneumonia, a new study found. Blocking cholesterol build-up inside arteries, statins reduce the risk of heart disease. But a clinical trial of Crestor, made by the London-based drug company AstraZeneca, suggests the benefits of statins extend beyond the heart. “Participants randomly assigned to receive rosuvastatin [Crestor is the brand name] had a modest reduction in the” View full resource at abcnews.go.com

Most Recently Shared on March 19, 2012 at 10:08 pm By:

Statins May Lower Pneumonia Risk: Statins, the same drugs that help millions of Americans control their choleste... http://t.co/zpqrdxzL

CardioBusiness Health Magazine

JAMA: Uphill battle to reach 2020 goals on CVD reduction

cardiovascularbusiness.com — “The American Heart Association (AHA) faces hurdles in its goal to reduce cardiovascular disease (CVD) mortality and morbidity by 20 percent by 2020, judging from results of a study published online March 16 in the Journal of the American Medical Association. An analysis of time trends in seven cardiovascular health metrics found few people meet most of the metrics, but those who do have a much lower risk of all-cause, CVD and ischemic heart disease mortality.” View full resource at cardiovascularbusiness.com

Most Recently Shared on March 19, 2012 at 4:54 pm By:

Will @Heartnews miss its mark? 20% by 2020 still may be an uphill battle. Read the story here: http://t.co/5MKibsuo #cardiovasculardisease

PhysOrg Health News Health News

Hip fracture surgery type impacts future fracture risk

medicalxpress.com — “(HealthDay) -- Patients with a primary proximal femoral fracture who undergo closed reduction and percutaneous pinning have a significantly increased risk of subsequent contralateral hip fracture compared with those who undergo arthroplasty, according to a study published in the March 7 issue of The ...” View full resource at medicalxpress.com

Most Recently Shared on March 17, 2012 at 10:12 am By:

Hip fracture surgery type impacts future fracture risk http://t.co/qUdzUbGd

News-Medical.Net Health News

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

news-medical.net — “VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.” View full resource at news-medical.net

Most Recently Shared on March 17, 2012 at 7:37 am By:

Arthritis News: Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis: VBL The... http://t.co/eCFxg2Bp

VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated ...” View full resource at finance.yahoo.com

Most Recently Shared on March 17, 2012 at 1:37 am By:

Psoriasis OW OW Health

VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking... http://t.co/Znutigbd